ZYUS Life Sciences Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Brent Zettl
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 48.2% |
| Management average tenure | 1.5yrs |
| Board average tenure | no data |
Recent management updates
CEO
Brent Zettl (61 yo)
no data
Tenure
Mr. Brent H. Zettl serves as the Chief Executive Officer, President, Secretary and Director of ZYUS Life Sciences Inc. Mr. Zettl has been the Chief Executive Officer and President of CanniMed Therapeutics...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | no data | no data | 48.23% CA$ 40.7m | |
| Chief Financial Officer | 2.4yrs | no data | 0.013% CA$ 11.1k | |
| Chief Strategy & Investment Officer | no data | no data | 0.18% CA$ 149.0k | |
| Director of Investor Relations & Capital Markets | less than a year | no data | no data | |
| Vice President of Legal Affairs | no data | no data | 0.14% CA$ 118.2k | |
| Chief Medical Officer | 3.9yrs | no data | 0.14% CA$ 114.8k | |
| Vice President of Clinical Research | less than a year | no data | 0.091% CA$ 76.9k |
1.5yrs
Average Tenure
Experienced Management: ZYUS's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.